Test Price
2,800 AED✅ Home Collection Available
CAV3 Gene Mutation Analysis (NGS) for Elevated Serum Creatine Kinase (CPK) in UAE | 2,800 AED | DHA Licensed Diagnostic Genomics
Executive Summary & Core Metrics
Core Metrics Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed clinical geneticists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CAV3 gene mutation analysis utilizes next-generation sequencing to detect pathogenic variants associated with persistently elevated serum creatine kinase levels, a critical biomarker for inherited neuromuscular disorders. This molecular assay enables precise diagnosis of caveolinopathies, rippling muscle disease, and asymptomatic hyperCKemia, facilitating timely neurological intervention and informed family counseling.
| Feature | Our Test | Closest Alternative (Standard CPK Blood Test) |
|---|---|---|
| Precision | 99.9% sensitivity for CAV3 mutations via NGS | Measures enzyme level, no genetic cause identified |
| Method | Next-Generation Sequencing (NGS) | Spectrophotometric enzyme assay |
| Turnaround | 3-4 Weeks | Same day |
Physician Insight & Safety Protocols
"Persistent elevation of serum creatine kinase warrants a genetic investigation. CAV3 sequencing offers a molecular window into muscle membrane integrity. Clinical correlation with family history and neurological examination is essential for accurate interpretation and management." — Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory & Pretest Considerations
Patients should continue all prescribed medications unless explicitly advised otherwise by their treating physician. Agents such as statins, corticosteroids, and muscle relaxants can influence serum CK levels and must be evaluated in context. A pretest genetic counseling session is mandatory to review family pedigree and discuss potential implications of identified variants.
Safety Exclusion Criteria & Emergency Red Flags
- Do not proceed with this test if you are experiencing acute rhabdomyolysis, uncontrolled cardiac arrhythmias, or severe muscle weakness — seek emergency medical attention immediately.
- New-onset dark cola-colored urine, chest pain during exertion, or rapidly progressive weakness requires urgent clinical evaluation rather than scheduled genetic testing.
- Pregnant individuals must inform the phlebotomist; deferring testing until after delivery may be recommended to avoid unnecessary anxiety.
- Minors require parental or guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the CAV3 gene test for elevated CPK?
Direct Answer: This molecular test analyzes the caveolin-3 gene using next-generation sequencing to identify mutations responsible for persistently elevated creatine kinase levels. It is indicated for individuals with unexplained hyperCKemia, suspected caveolinopathy, or a family history of neuromuscular disorders.
2. How should I prepare for the CAV3 genetic blood test?
Direct Answer: A mandatory pretest genetic counseling session is required to map your family pedigree and discuss the implications of potential findings. Fasting is not required; however, avoid strenuous exercise for 24 hours before sample collection to prevent transient CK elevation that could confound clinical correlation.
3. Who are the top specialists managing CAV3-related hyperCKemia?
Direct Answer: Clinical geneticists, neurologists, and sports medicine specialists collaborate to interpret results and guide management. Depending on the variant identified, care may involve neuromuscular specialist referral, athletic participation clearance, or cascade screening of at-risk family members.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic information is handled with strict confidentiality under DHA facility license no. 1143. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | CAV3 Gene Mutation Analysis (NGS) for Elevated Serum Creatine Kinase (CPK) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | R74.8 (Abnormal levels of other serum enzymes) |
| LOINC Code | 95209-3 (CAV3 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians